baxter
Baxter planning $1 billion plasma facility for Atlanta
April 24, 2012Manufacturing and Production Atlanta, baxter, manufacturing, production
Baxter International has unveiled plans to build a major new manufacturing complex for its plasma-based therapies in Atlanta in the …
Quality problems lead to short-term layoffs at Baxter Ireland
February 22, 2011Manufacturing and Production Dianeal, Extraneal, Ireland, Nutrineal, baxter, job cuts, manufacturing compliance, peritoneal dialysis
A contaminated production line at a facility in Ireland operated by Baxter Healthcare has resulted in 150 staff being laid …
Takeda and Baxter make pandemic flu vaccine plans for Japan
December 7, 2010Manufacturing and Production Takeda, baxter, pharma manufacturing, vaccine manufacturing, vaccines
Takeda has made another move into the vaccines sector with the expansion of a deal with Baxter International for the …
Pharma manufacturing news in brief
May 24, 2010Manufacturing and Production Angel Biotech, Halozyme, Johnson Matthey, Ranbaxy, Sagent Pharmaceuticals, baxter
There are more quality problems to report on the manufacturing beat this week, with recalls for Ranbaxy, Halozyme/Baxter and Sagent …
Manufacturing news in brief
April 6, 2010Manufacturing and Production NIB, Valeant, Warner Chilcott, baxter
This week’s round-up of recent developments in the pharmaceutical manufacturing arena sees a new facility build for Ireland’s HKPB and …
Baxter Alzheimer’s candidate shows promise
March 20, 2010Research and Development Alzheimer's, baxter
Baxter’s Gammagard has shown promise in treating Alzheimer’s disease, with patients showing better cognitive function and less brain enlargement than …
Baxter’s H1N1 vaccine set for European licence
October 5, 2009Sales and Marketing baxter, h1n1
Baxter’s swine-flu vaccine is third in line for approval in Europe, behind already approved rivals from GSK and Novartis.Regulatory advisors …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
